Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1998
05/07/1998WO1998018794A1 Novel heterocyclic amide compounds and medicinal uses thereof
05/07/1998WO1998018763A1 Tetrahydroisoquinoline derivatives
05/07/1998WO1998018493A2 Conjugates useful in the treatment of prostate cancer
05/07/1998WO1998018491A1 Methods and compositions for dietary supplementation
05/07/1998WO1998018487A1 Prophylactic/remedial agent
05/07/1998WO1998018486A1 Use of leptin to stimulate hematopoiesis
05/07/1998WO1998018485A1 The use of calpain inhibitors to treat ocular neural pathology
05/07/1998WO1998018484A1 Therapeutic agent and method for feline aids virus infections and feline atopic dermatitis
05/07/1998WO1998018483A1 Oncostatin m for treating inflammation
05/07/1998WO1998018482A1 Use of lh-rh antagonists as diagnostic agent
05/07/1998WO1998018481A1 Combination therapy for the treatment of diabetes and obesity
05/07/1998WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
05/07/1998WO1998018467A1 Compositions for the treatment of renal failure, comprising l-carnosine
05/07/1998WO1998018456A1 Protease-activated receptor 3 and uses thereof
05/07/1998WO1998018455A1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules
05/07/1998WO1998018437A1 An oral care product comprising a mutan binding domain
05/07/1998WO1998011243A3 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
05/07/1998WO1998011226A3 Mammalian chemokines, related reagents
05/07/1998WO1998010069A3 E25a protein, methods for production and use thereof
05/07/1998WO1998009985A3 Anti-inflammatory peptides and uses thereof
05/07/1998WO1998008965A3 Cd95 regulatory gene sequences and transcription factors
05/07/1998WO1998008536A3 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
05/07/1998WO1998007855A3 Secreted proteins and polynucleotides encoding them
05/07/1998WO1998007415A3 Methods for prevention of cellular proliferation and restenosis
05/07/1998WO1998006851A3 DEFINING EPITOPES OF THE OUTER MEMBRANE PROTEIN CopB OF $i(MORAXELLA CATARRHALIS)
05/07/1998WO1998006841A3 Two human nsp-like proteins
05/07/1998WO1998006823A3 Cytokine-free culture of dendritic cells
05/07/1998WO1998006747A3 Uses for wnt polypeptides
05/07/1998WO1998006248A3 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH α4β7 INTEGRIN
05/07/1998WO1998005363A3 Polypeptides having a single covalently bound n-terminal water-soluble polymer
05/07/1998WO1998005331A3 Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
05/07/1998WO1998002558A3 Chimeric receptors for jak-stat signal transduction
05/07/1998WO1998000538A3 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization
05/07/1998WO1997046683A3 Polynucleotides encoding secreted proteins
05/07/1998WO1997045543A3 Cc chemokine receptor 5, antibodies thereto, transgenic animals
05/07/1998WO1997045542A3 Cell growth regulatory genes
05/07/1998WO1997044461A3 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/07/1998DE19644994A1 Diagnostisches Mittel Diagnostic agent
05/07/1998CA2665133A1 Neutrokine .alpha.
05/07/1998CA2272825A1 Novel human lim proteins
05/07/1998CA2271720A1 Streptococcus pneumoniae polynucleotides and sequences
05/07/1998CA2270901A1 Delivery construct for antisense nucleic acids and methods of use
05/07/1998CA2270401A1 Novel hepatitis b virus inhibitors
05/07/1998CA2270223A1 Methods and compositions for dietary supplementation
05/07/1998CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents
05/07/1998CA2269865A1 Process aimed at evidencing the state of a malignant cell and process for treatment
05/07/1998CA2269801A1 Stable expression of triple helical proteins
05/07/1998CA2269738A1 Targeted cytolysis of cancer cells
05/07/1998CA2269722A1 Oligomers which inhibit the expression of interleukin genes
05/07/1998CA2269663A1 Streptococcus pneumoniae antigens and vaccines
05/07/1998CA2269660A1 Combination therapy for the treatment of diabetes and obesity
05/07/1998CA2269642A1 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
05/07/1998CA2269635A1 Protease-activated receptor 3 and uses thereof
05/07/1998CA2268750A1 Human p2x purinoreceptor
05/07/1998CA2268738A1 Conjugates useful in the treatment of prostate cancer
05/07/1998CA2268027A1 Novel flt-3 receptor agonists
05/07/1998CA2268023A1 Circularly permuted polypeptides as novel stem cell factor receptor agonists
05/07/1998CA2268001A1 Circularly permuted erythropoietin receptor agonists
05/07/1998CA2241458A1 Compositions for the treatment of renal failure, comprising l-carnosine
05/06/1998EP0839915A1 Secretory immunoglobulin A as a mucosal vaccine delivery system
05/06/1998EP0839910A2 Spo-rel, a Staphylococcus relA/spot homologue
05/06/1998EP0839908A2 A novel human ETS family member, ELF3
05/06/1998EP0839831A2 Single chain gonadotropin
05/06/1998EP0839798A2 Intermediates for preparating non-peptide retroviral protease inhibitors
05/06/1998EP0839525A1 Sustained-release preparation
05/06/1998EP0839207A2 p16 EXPRESSION CONSTRUCTS AND THEIR APPLICATION IN CANCER THERAPY
05/06/1998EP0839204A2 Method for producing haemin proteins using plant cells, resulting proteins and products containing same
05/06/1998EP0839199A1 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses
05/06/1998EP0839196A2 Human ctla-8 and uses of ctla-8-related proteins
05/06/1998EP0839194A1 Protein p53 variants and their therapeutic uses
05/06/1998EP0839191A1 Autoreactive peptides from human glutamic acid-decarboxylase (gad)
05/06/1998EP0839183A1 Immortalized epithelial tumor cell
05/06/1998EP0839157A1 Colostrum derived growth factor
05/06/1998EP0839156A1 Anti-fungal peptides
05/06/1998EP0839155A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES
05/06/1998EP0839154A1 Biologically active peptides and compositions, their use
05/06/1998EP0839125A1 Novel cationic lipids and the use thereof
05/06/1998EP0839055A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
05/06/1998EP0839054A1 Tumor- or cell-specific herpes simplex virus replication
05/06/1998EP0839049A1 A stabilized pharmaceutical formulation comprising a growth hormone pre-treated with zinc and optionally lysine or calcium ions
05/06/1998EP0839048A1 Method of treating epilepsy with brain derived neurotrophic factor
05/06/1998EP0839047A1 Pharmaceutical compositions containing protein
05/06/1998EP0839046A1 Tnf receptor and steroid hormone in a combined therapy
05/06/1998EP0839045A1 Interleukin-1 receptor-associated protein kinase and assays
05/06/1998EP0839032A1 Hydroxyl ions as unique therapeutic agents and compounds that modulate ions, compounds
05/06/1998EP0742790A4 Substituted purines and oligonucleotide cross-linking
05/06/1998EP0711355A4 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
05/06/1998EP0438519B1 Therapeutic peptides
05/06/1998CN1181020A Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation mthod therefor and pharmaceutical compositions containing same
05/06/1998CN1181019A Combination compositions containing benazepril or beazeprilat and valsartan
05/06/1998CN1181018A 多功能酶 Multifunctional enzyme
05/06/1998CN1181015A Reduction of infarct volume using citicoline
05/06/1998CN1181014A A pharmaceutical composition containing N-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
05/06/1998CN1180709A Neopolynucleotide and polypeptide gene of genetic multiple exogenetic bone wart family
05/06/1998CN1180570A High polymer antineoplastic guide medicine and preparation method thereof
05/06/1998CN1180569A Preparation for medicine feeding through nose
05/05/1998US5747661 Isolated nucleic acid; genetic engineering
05/05/1998US5747660 Nucleic acid encoding prostaglandin F2α receptor regulatory protein
05/05/1998US5747659 Increased egg lay; fertility agents
05/05/1998US5747655 Nerve cells, geonomes dna sequences and amino acid sequences
1 ... 2628 2629 2630 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 ... 3163